PP-021 Quality study of intravenous mixtures after the implementation of double check

BackgroundAvoiding errors related to drug development, which can compromise the patient’s life, is essential in our profession.PurposeTo describe the quality of sterile intravenous mixtures (IVM) after implantation of a double check and to evaluate the effectiveness of the measures adopted since its...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of hospital pharmacy. Science and practice Vol. 23; no. Suppl 1; p. A203
Main Authors Sánchez, S Vicente, Molina, O García, Pulido, M Valderrey, Contreras, MC Muñoz, Carmona, J Mateo, Nieto, A de La Rubia
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 01.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BackgroundAvoiding errors related to drug development, which can compromise the patient’s life, is essential in our profession.PurposeTo describe the quality of sterile intravenous mixtures (IVM) after implantation of a double check and to evaluate the effectiveness of the measures adopted since its implementation.Material and methodsRetrospective observational study in which double check record sheets were revised for 3 periods of 15 days, made over a year. The aspects evaluated were: name and concentration of the drug used, prepared dose and mL of drug used, number of new vials started, checking calculations of used and surplus mL, expiration of vials used, labelling, physicochemical characteristics of IVM, packaging, and sheets duly signed and filled out by the pharmacist and nurse. In addition it was confirmed that preparation labels contained lot and caducity of the vials used to ensure traceability of the IVM. The double check was by nursing staff on the ward; this nurse was different from the nurse who made the IVM and after the pharmacist checked correct completion of the form.Results712 IVM were developed during the 3 study periods (169, 219 and 324, respectively). They were revised 98.2%, 99% and 100% of the IVM and non-conformity with the double check was 20.7%, 20.5% and 12.6%. The most common errors produced were incomplete double checks in 62.8%, 33.3% and 82.1%, errors in calculations in 17.4% 22.2% and 7.1%, and no annotation of the lot and expiration in 14.2%, 28.8% and 3.6%, respectively. IVM with the record sheet but with a blank checklist were 1.8%, 3.2% and 1.2%. The measures introduced were: reinforcing the training of nurses to insist on the importance of the correct performance of the double check for the prevention of medication errors, to underline the importance of being able to perform the traceability of IVM, to check with automatic methods the calculations made and to visualise the correct volume of the mixture with higher optical precision.ConclusionDouble check provides greater security in the prevention and correction of problems related to drugs. Implementation of specific measures continuously has gradually reduced the number of errors.References and/or AcknowledgementsBest practice guidelines for preparation of drugs in the pharmacy servicesNo conflict of interest.
AbstractList BackgroundAvoiding errors related to drug development, which can compromise the patient’s life, is essential in our profession.PurposeTo describe the quality of sterile intravenous mixtures (IVM) after implantation of a double check and to evaluate the effectiveness of the measures adopted since its implementation.Material and methodsRetrospective observational study in which double check record sheets were revised for 3 periods of 15 days, made over a year. The aspects evaluated were: name and concentration of the drug used, prepared dose and mL of drug used, number of new vials started, checking calculations of used and surplus mL, expiration of vials used, labelling, physicochemical characteristics of IVM, packaging, and sheets duly signed and filled out by the pharmacist and nurse. In addition it was confirmed that preparation labels contained lot and caducity of the vials used to ensure traceability of the IVM. The double check was by nursing staff on the ward; this nurse was different from the nurse who made the IVM and after the pharmacist checked correct completion of the form.Results712 IVM were developed during the 3 study periods (169, 219 and 324, respectively). They were revised 98.2%, 99% and 100% of the IVM and non-conformity with the double check was 20.7%, 20.5% and 12.6%. The most common errors produced were incomplete double checks in 62.8%, 33.3% and 82.1%, errors in calculations in 17.4% 22.2% and 7.1%, and no annotation of the lot and expiration in 14.2%, 28.8% and 3.6%, respectively. IVM with the record sheet but with a blank checklist were 1.8%, 3.2% and 1.2%. The measures introduced were: reinforcing the training of nurses to insist on the importance of the correct performance of the double check for the prevention of medication errors, to underline the importance of being able to perform the traceability of IVM, to check with automatic methods the calculations made and to visualise the correct volume of the mixture with higher optical precision.ConclusionDouble check provides greater security in the prevention and correction of problems related to drugs. Implementation of specific measures continuously has gradually reduced the number of errors.References and/or AcknowledgementsBest practice guidelines for preparation of drugs in the pharmacy servicesNo conflict of interest.
Background Avoiding errors related to drug development, which can compromise the patient's life, is essential in our profession. Purpose To describe the quality of sterile intravenous mixtures (IVM) after implantation of a double check and to evaluate the effectiveness of the measures adopted since its implementation. Material and methods Retrospective observational study in which double check record sheets were revised for 3 periods of 15 days, made over a year. The aspects evaluated were: name and concentration of the drug used, prepared dose and mL of drug used, number of new vials started, checking calculations of used and surplus mL, expiration of vials used, labelling, physicochemical characteristics of IVM, packaging, and sheets duly signed and filled out by the pharmacist and nurse. In addition it was confirmed that preparation labels contained lot and caducity of the vials used to ensure traceability of the IVM. The double check was by nursing staff on the ward; this nurse was different from the nurse who made the IVM and after the pharmacist checked correct completion of the form. Results 712 IVM were developed during the 3 study periods (169, 219 and 324, respectively). They were revised 98.2%, 99% and 100% of the IVM and non-conformity with the double check was 20.7%, 20.5% and 12.6%. The most common errors produced were incomplete double checks in 62.8%, 33.3% and 82.1%, errors in calculations in 17.4% 22.2% and 7.1%, and no annotation of the lot and expiration in 14.2%, 28.8% and 3.6%, respectively. IVM with the record sheet but with a blank checklist were 1.8%, 3.2% and 1.2%. The measures introduced were: reinforcing the training of nurses to insist on the importance of the correct performance of the double check for the prevention of medication errors, to underline the importance of being able to perform the traceability of IVM, to check with automatic methods the calculations made and to visualise the correct volume of the mixture with higher optical precision. Conclusion Double check provides greater security in the prevention and correction of problems related to drugs. Implementation of specific measures continuously has gradually reduced the number of errors. References and/or Acknowledgements Best practice guidelines for preparation of drugs in the pharmacy services No conflict of interest.
Author Sánchez, S Vicente
Pulido, M Valderrey
Molina, O García
Nieto, A de La Rubia
Contreras, MC Muñoz
Carmona, J Mateo
Author_xml – sequence: 1
  givenname: S Vicente
  surname: Sánchez
  fullname: Sánchez, S Vicente
  organization: Hospital Virgen de La Arrixaca, Hospital Pharmacist, Murcia, Spain
– sequence: 2
  givenname: O García
  surname: Molina
  fullname: Molina, O García
  organization: Hospital Virgen de La Arrixaca, Hospital Pharmacist, Murcia, Spain
– sequence: 3
  givenname: M Valderrey
  surname: Pulido
  fullname: Pulido, M Valderrey
  organization: Hospital Virgen de La Arrixaca, Hospital Pharmacist, Murcia, Spain
– sequence: 4
  givenname: MC Muñoz
  surname: Contreras
  fullname: Contreras, MC Muñoz
  organization: Hospital Virgen de La Arrixaca, Hospital Pharmacist, Murcia, Spain
– sequence: 5
  givenname: J Mateo
  surname: Carmona
  fullname: Carmona, J Mateo
  organization: Hospital Virgen de La Arrixaca, Hospital Pharmacist, Murcia, Spain
– sequence: 6
  givenname: A de La Rubia
  surname: Nieto
  fullname: Nieto, A de La Rubia
  organization: Hospital Virgen de La Arrixaca, Hospital Pharmacist, Murcia, Spain
BookMark eNp90EtLw0AQB_BFKlhrv8OC59R9Z_coxRcUrKB4XHaTCUnNo242Ym9e_KJ-ElOqHj3NHP4zw_xO0aTtWkAIU7KglKsL2JTb0oUmYYSqhBCiU7kQihyhKSMiTYxRYvLXS3WC5n1feSI510ZwM0XP63VCGP36-HwYXF3FHe7jkO9wV-CqjcG9QdsNPW6q9zgE6LErIgQcS8BVs62hgTa6WHXtfiDvBl8DzkrIXs7QceHqHuY_dYaerq8el7fJ6v7mbnm5SjwlhCdOeZNnhXcmLzRww53MqcoELQCMKUCAMlqkijs9Psw8eKdzwrT3GXckk3yGzg97t6F7HaCPdtMNoR1PWiYlS4UWjP-XoqkWUo1yYkzxQ8o3G7sNVePCzlJi99T2l9ruqe2B2o7U_Bu68HbA
ContentType Journal Article
Copyright 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
2016 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml – notice: 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: 2016 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID 3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
BTHHO
CCPQU
FYUFA
GHDGH
K9.
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.1136/ejhpharm-2016-000875.460
DatabaseName ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
BMJ Journals
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList
ProQuest One Academic Eastern Edition
ProQuest One Academic Eastern Edition
Database_xml – sequence: 1
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2047-9964
EndPage A203
ExternalDocumentID 4036120461
GroupedDBID 0R~
3V.
53G
7X7
8FI
8FJ
AAYAA
ABKRM
ABUWG
ABVAJ
ABWEH
ADBBV
ADMRH
AFKRA
AHMBA
AHQMW
AJYBZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BENPR
BPHCQ
BTHHO
C45
CCPQU
CXRWF
EBS
EJD
FYUFA
H13
HAJ
HMCUK
HYE
OK1
OVD
PQQKQ
PROAC
RHI
RMJ
RPM
TEORI
UKHRP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-b1003-a6b9dcfba9df8e393a5d16c41fee99fe4e6984763a81132beba8d028bbc3a0c53
IEDL.DBID 7X7
ISSN 2047-9956
IngestDate Thu Oct 10 20:48:20 EDT 2024
Thu Oct 10 16:38:46 EDT 2024
Wed Aug 21 03:28:44 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue Suppl 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b1003-a6b9dcfba9df8e393a5d16c41fee99fe4e6984763a81132beba8d028bbc3a0c53
PQID 1784560084
PQPubID 2040966
ParticipantIDs proquest_journals_2552748423
proquest_journals_1784560084
bmj_primary_10_1136_ejhpharm_2016_000875_460
PublicationCentury 2000
PublicationDate 20160300
20160301
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: 20160300
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle European journal of hospital pharmacy. Science and practice
PublicationYear 2016
Publisher BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group LTD
SSID ssib053389439
ssj0000605265
ssib018287486
Score 2.0107505
Snippet BackgroundAvoiding errors related to drug development, which can compromise the patient’s life, is essential in our profession.PurposeTo describe the quality...
Background Avoiding errors related to drug development, which can compromise the patient's life, is essential in our profession. Purpose To describe the...
SourceID proquest
bmj
SourceType Aggregation Database
Publisher
StartPage A203
SubjectTerms Medical errors
Pharmacists
Title PP-021 Quality study of intravenous mixtures after the implementation of double check
URI http://dx.doi.org/10.1136/ejhpharm-2016-000875.460
https://www.proquest.com/docview/1784560084
https://www.proquest.com/docview/2552748423
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwELZoWVgQCBCPUnlgJFDXjmNPCFARQgJVCES3yE_RQh_QFsHGwh_ll-BzEhhAzFaW7y53n8933yG0Rz3VLBM2sUb4hLnUJzp1JKEsValixDkP08iXV_z8ll300l5ZcJuWbZVVTIyB2o4N1MgP2yAVxkTI_keTpwS2RsHrarlCo4YWSbvFwauz3nc6JVHM_UceLTAbUBuX3zWYFge1E-hybINgAQx5Vs0-lB-6wf0E5KODIxEO09eB2h8w0LKs6eHgV-yOCelsBS2XTBIfF6ZfRQtutIbuut0k5NPP949CHOMNR_1YPPa4D2XclyjJiof9V3g5mOK4IhwHEoj7w6qTHEwFH9jxXD86HKxqHtbR7Vnn5vQ8KXcnJJpAu5niWlrjtZLWC0clVakl3DDinZPSO-a4DImJUyVg17x2WgkbuIbWhqqWSekGqo_GI7eJcDCgadtUep4RZkWglEJxozNPlAy3Q7-F9gMe-aRQx8jjrYLyvIIvB_jyAr48wLeFGhVwefm_THOSCQbcS7A_j3-Mv_3_8Q5aKqwFTWINVJ89z91uYA0z3Yyu0USLJ52r7nUzlnW-APlRwDM
link.rule.ids 315,783,787,12069,21401,27937,27938,31732,33757,43323,43818,74080,74637
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ25TgMxEIYtjgIaBALEjQtKlsSx12tXCCFQgARREJHO8ikC5IAAgo6GF-VJ8OwRChC1tc3MrOf3ePwNQns0UMMy4RJnRUiYT0NiUk8SylKdaka8D_AauX3Jmx123k27ZcFtXLZVVntivlG7oYUaea0BqDAmYvY_HD0mMDUKblfLERrTaBY4XBDnWXeSTkkOc__Bo0VlA7RxOanB1DnQTqDLsQHAAnjkWTX7UF7zd7cjwEfHQCIcXl9HaX_AgGU5bfp3v_buPCGdLqKFUknio8L1S2jKD5bRzdVVEvPp18dnAcd4xzk_Fg8D7kEZ9zVHsuJ-7w1uDsY4HxGOowjEvX7VSQ6ugg_c8MU8eBy9au9XUOf05Pq4mZSzExJDoN1McyOdDUZLF4SnkurUEW4ZCd5LGTzzXMbExKkWMGveeKOFi1rDGEt13aZ0Fc0MhgO_hnB0oG24VAaeEeZElJRCc2uyQLSMp8OwjvajPdSooGOo_FRBuarMp8B8qjCfiuZbR1uV4VT5v4wVyQQD7SXYn8s_zt_4f3kXzTWv2y3VOru82ETzheegYWwLzTw_vfjtqCCezU4eJt-ILsBw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELaaRkJcEKggWgL4wJElcez12qeKPqJCSxQhInKz_FTTkgdNitpbL_2j_JLO7IMcQJytvczMer4Zf_MNIe944k4UKmTBq5SJmKfM5ZFlXOQ2t4LFmHAa-ctQnozF50k-qflPq5pW2dyJ5UUdFh575N0-SoUJBdm_m2paxOhosL_8meEGKXxprddptEi7EJJDIdY-OB6OvjbRxUpp941YGuAc1B7XfzoyPYnaJ8h57KN8AY58NtQfLrvx4nyJYtIQVkziLDYA_Q8ClS1bbnbx101epqfBU_KkxpX0YxUIz8hWnO-Q76NRBtn19919JZVxS0s1WbpIdIpN3V-lQCudTW_wHWFFy4XhFCAhnc4aXjk6Dj8Ii2v3I1Lwsb98TsaD42-HJ1m9SSFzDMlnVjodfHJWh6Qi19zmgUkvWIpR6xRFlBrSlORW4eZ5F51VAZCHc57bns_5C7I9X8zjS0LBnb4fcp1kwURQADCVld4ViVkNtWLaJe_BHmZZaWWYssbg0jTmM2g-U5nPgPl2SacxnKn_npVhhRKIxJT45_EmFPb-f_yWPIIYMWefhqevyOPKccge65Dt9dV1fA1wYu3e1HHyAA4wxhM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PP-021%E2%80%85Quality+study+of+intravenous+mixtures+after+the+implementation+of+double+check&rft.jtitle=European+journal+of+hospital+pharmacy.+Science+and+practice&rft.au=S%C3%A1nchez%2C+S+Vicente&rft.au=Molina%2C+O+Garc%C3%ADa&rft.au=Pulido%2C+M+Valderrey&rft.au=Contreras%2C+MC+Mu%C3%B1oz&rft.date=2016-03-01&rft.issn=2047-9956&rft.eissn=2047-9964&rft.volume=23&rft.issue=Suppl+1&rft.spage=A203&rft_id=info:doi/10.1136%2Fejhpharm-2016-000875.460&rft.externalDBID=ttp%3A%2F%2Fejhp.bmj.com%2Fcontent%2F23%2FSuppl_1%2FA203.2.full.pdf
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9956&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9956&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9956&client=summon